01232018Headline:

Chicago-Land, Illinois

HomeIllinoisChicago-Land

Jessica Hoerman

Pennsylvania Congressman Plans to Introduce “E-Free Act” to Ban Essure

U.S. Representative Mike Fitzpatrick (R-PA, 8th District) will hold a press conference today to announce his “E-Free Act,” a bipartisan bill to Congress that would ban the Essure contraceptive device. Essure, which is manufactured by Bayer, is a flexible, nickel-titanium […]

Steven Davis

FDA Asks Pfizer to Change Zoloft Label

The U.S. Food and Drug Administration (FDA) has asked Pfizer to change Zoloft’s label to reflect the warnings of researchers who have found increased risk of congenital cardiac defects in infants whose mothers took the medication. According to Pfizer, the […]

Steven Davis

Xarelto Lawsuit Alleges Drug Isn’t Effective, Even When Taken as Directed

A lawsuit filed last week in Pennsylvania state court against Janssen Pharmaceuticals alleges that the company’s recommended once a day dosage for the blockbuster drug Xarelto isn’t effective for a full 24 hours. A plaintiff with non-valvular atrial fibrillation who […]

Eric Terry

NBC News Says Bard Was Warned That Recovery Filter Was Faulty

At least 27 deaths have been connected to the Bard Recovery IVC (inferior vena cava) filter over the past decade, according to an NBC News investigation. NBC News reported that besides the 27 deaths associated with the Recovery filter; government […]

Eric Terry

J&J Receives Slap on the Hand While Employees Soar, Despite Association with Risperdal

According to America’s Most Admired Lawbreaker, a special report published in the Huffington Post, Johnson & Johnson (J&J) has never come forward with information that any of its employees were disciplined or fired for illegally promoting the antipsychotic drug Risperdal. […]

Jessica Hoerman

Does the Little Pink Pill “Even the Score” For Women?

For the first time ever, the FDA has approved a libido drug for women. The little pink pill, Addyi (flibanserin), is being marketed by Sprout Pharmaceuticals as the drug that will bring gender equality to the field of sexual medicine. […]

Steven Davis

Future of Anticoagulants Uncertain, Holds Many Options

Patients who require anticoagulation will have more and hopefully better options over the next 10 years, according to a report published by the International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP). What are Anticoagulants? Anticoagulants are meant to reduce or […]

Steven Davis

First Xarelto Bellwether Trials Set for August 2016

A series of Xarelto bellwether trials before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana may begin as soon as August 2016. The cases are part of a federal multidistrict litigation (MDL), a consolidation of approximately 550 […]

Steven Davis

Pradaxa Antidote May be Approved By End of 2015

Early results from a new study indicate that an experimental drug is able to successfully reverse the blood-thinning effects of the anticoagulant drug Pradaxa, and may be ready for release toward the end of 2015. In April 2015, the U.S. […]

Steven Davis

SGLT2 Inhibitors Improve Blood Sugar Levels but Cause Serious Side Effects

Several drugs that are part of a new class of diabetes drugs, the Sodium-glucose co-transporter 2 (SGLT2) inhibitors, were approved by the U.S. Food and Drug Administration (FDA) despite the fact that they have some disturbing side effects. These medications […]